Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-11 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
S | Ordinary Shares | D | 2400 | $5.00 - $5.00 | $12,000 |
| 2024-11-11 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
S | Ordinary Shares | D | 2400 | $5.00 - $5.00 | $12,000 |
| 2024-11-06 | Verona Pharma plc | EBSWORTH DAVID R
(Director) |
P | Ordinary Shares | A | 39360 | $4.80 - $4.80 | $188,880 |
| 2024-11-06 | Verona Pharma plc | ACKERMANN CHRISTINA
(Director) |
P | Ordinary Shares | A | 41880 | $4.74 - $4.74 | $198,385 |
| 2024-11-01 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
S | Ordinary Shares | D | 141032 | $4.38 - $4.39 | $618,656 |
| 2024-11-01 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
S | Ordinary Shares | D | 129672 | $4.38 - $4.39 | $568,385 |
| 2024-11-01 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
F | Ordinary Shares | D | 245952 | $4.24 - $4.24 | $1,043,131 |
| 2024-10-30 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
A | Ordinary Shares | A | 1000000 | $0.00 - $0.00 | $0 |
| 2024-11-01 | Verona Pharma plc | Rickard Kathleen A.
(Chief Medical Officer) |
F | Ordinary Shares | D | 65936 | $4.24 - $4.24 | $279,647 |
| 2024-10-30 | Verona Pharma plc | Rickard Kathleen A.
(Chief Medical Officer) |
A | Ordinary Shares | A | 350000 | $0.00 - $0.00 | $0 |
| 2024-11-01 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
F | Ordinary Shares | D | 245952 | $4.24 - $4.24 | $1,043,131 |
| 2024-10-30 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
A | Ordinary Shares | A | 1000000 | $0.00 - $0.00 | $0 |
| 2024-10-30 | Verona Pharma plc | Fisher Andrew
(General Counsel) |
A | Ordinary Shares | A | 300000 | $0.00 - $0.00 | $0 |
| 2024-10-24 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
S | Ordinary Shares | D | 144560 | $4.38 - $4.38 | $632,760 |
| 2024-10-23 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
S | Ordinary Shares | D | 144816 | $4.38 - $4.38 | $633,895 |
| 2024-10-18 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
S | Ordinary Shares | D | 514152 | $4.38 - $4.39 | $2,253,236 |
| 2024-10-18 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
S | Ordinary Shares | D | 525768 | $4.38 - $4.38 | $2,303,771 |
| 2024-09-11 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
S | Ordinary Shares | D | 600000 | $3.76 - $3.76 | $2,254,320 |
| 2024-08-07 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
F | Ordinary Shares | D | 314800 | $2.62 - $2.62 | $824,776 |
| 2024-08-07 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
A | Ordinary Shares | A | 800000 | $0.00 - $0.00 | $0 |
| 2024-08-07 | Verona Pharma plc | Rickard Kathleen A.
(Chief Medical Officer) |
F | Ordinary Shares | D | 87904 | $2.62 - $2.62 | $230,308 |
| 2024-08-07 | Verona Pharma plc | Rickard Kathleen A.
(Chief Medical Officer) |
A | Ordinary Shares | A | 200000 | $0.00 - $0.00 | $0 |
| 2024-08-07 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
F | Ordinary Shares | D | 314800 | $2.62 - $2.62 | $824,776 |
| 2024-08-07 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
A | Ordinary Shares | A | 800000 | $0.00 - $0.00 | $0 |
| 2024-08-01 | Verona Pharma plc | Hahn Mark W
(Chief Financial Officer) |
F | Ordinary Shares | D | 88544 | $2.83 - $2.83 | $250,800 |
| 2024-08-01 | Verona Pharma plc | ZACCARDELLI DAVID
(President and CEO) |
F | Ordinary Shares | D | 88544 | $2.83 - $2.83 | $250,800 |
| 2024-08-01 | Verona Pharma plc | Rickard Kathleen A.
(Chief Medical Officer) |
F | Ordinary Shares | D | 106232 | $2.83 - $2.83 | $300,902 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |